Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Samsara Inc (IOT) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Samsara IncTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Samsara Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Samsara Inc trades at $41.33 (market cap $24.14B), while Relay Therapeutics Inc. Common Stock trades at $17.84 (market cap $3.82B). The key difference: Samsara Inc is far larger — about 6.3× Relay Therapeutics Inc. Common Stock's market cap, and Samsara Inc is more actively traded (5,372,580 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold Samsara Inc for 19 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

IOTRLAY
Market Cap
$24.14B$3.82B
Volume
5,372,5804,332,079
Sector
TechnologyHealth
52-Week High
$45.22$20.75
52-Week Low
$24.25$6.03
Typical Hold Time
19 Days0 Days
Enterprise Value
$23.38B$2.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Samsara Inc

Samsara (IOT) trades at $41.71, up 2.96% with strong bullish momentum. The stock shows robust technical strength with bullish moving averages and trades near resistance at $42. Fundamentally, the company demonstrates impressive revenue growth, reaching $1.8B in 2026 with a positive net income turnaround to $91M. Recent Q2 2027 earnings beat expectations with $0.20 EPS versus $0.16 estimate, driven by 30% annual recurring revenue growth and expanding large-customer adoption.

Outlook remains positive with 75% analyst buy ratings and $51.15 consensus target, representing 23% upside. Key opportunities include enterprise standardization trends and AI integration through Samsara MCP. Risks include elevated valuation multiples (P/E 274.8, P/S 13.01) and potential cash flow pressure despite strong operational performance. The stock's recent 72% rally warrants monitoring for sustainability beyond multiple expansion.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IOT

No sentiment data available yet.

RLAY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Samsara Inc

Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.

Read more on IOT →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →